NSAID Use in Patients with Kidney Disease

Introduction to NSAID-Induced Nephrotoxicity

NSAIDs should be avoided in patients with elevated urine microalbumin-to-creatinine ratio due to their potential to worsen kidney function and increase the risk of progression to more severe kidney disease, as recommended by the American Academy of Family Physicians and the American Diabetes Association 1, 2
The American Diabetes Association guidelines indicate that an elevated microalbumin-to-creatinine ratio (≥30 mg/g creatinine) requires special consideration for medication management, highlighting the importance of careful NSAID use in patients with early kidney damage 2

The risk of NSAID-induced nephrotoxicity increases with the degree of albuminuria, and patients with macroalbuminuria (urine albumin-to-creatinine ratio ≥300 mg/g creatinine) are at higher risk, as noted by the American Academy of Family Physicians and the American Diabetes Association 1, 2
Concurrent use of ACE inhibitors or ARBs plus diuretics can significantly increase the risk of acute kidney injury, creating a "triple whammy" effect, according to the American Academy of Family Physicians 1
Advanced age and heart failure or cirrhosis are also risk factors for NSAID-induced nephrotoxicity, as noted by the American Academy of Family Physicians 1

Monitor renal function, fluid retention, and electrolytes when using NSAIDs in patients with kidney disease, as recommended by the American Academy of Family Physicians 1
Check serum creatinine and potassium within 7 days of starting therapy, and monitor blood pressure regularly, as NSAIDs can increase blood pressure by approximately 5 mmHg, according to the American Academy of Family Physicians 1
Discontinue NSAIDs immediately if there are signs of worsening kidney function, such as an increase in serum creatinine by >30% or the development of hyperkalemia, as recommended by the American Academy of Family Physicians 1
The following table summarizes the definitions of microalbuminuria and macroalbuminuria:

Term	Definition
Microalbuminuria	30-299 mg/24h or UACR 30-299 mg/g creatinine
Macroalbuminuria	≥300 mg/24h or UACR ≥300 mg/g creatinine

3, 4, 5

Consider alternative therapies, such as acetaminophen (paracetamol) as first-line analgesic, topical NSAIDs, non-pharmacological approaches (physical therapy, heat/cold therapy), or judicious use of tramadol or other carefully selected opioids for short-term severe pain, as recommended by the American Academy of Family Physicians 1

The combination of NSAIDs with ACE inhibitors or ARBs significantly increases the risk of acute kidney injury, and diuretics further compound this risk, creating a "triple whammy" effect, according to the American Academy of Family Physicians 1
If a patient is on antihypertensive medications, monitor blood pressure closely and adjust antihypertensive doses as needed, as recommended by the American Academy of Family Physicians 1
For patients with eGFR <53 mL/min/1.73m² and increasing creatinine, discontinue nephrotoxic medications, particularly NSAIDs and COX-2 inhibitors, which increase the risk of heart failure worsening and hospitalization, as recommended by the European Heart Journal 6
Review medication dosing and adjust doses of renally cleared medications according to current eGFR, as suggested by the American College of Cardiology 7
Evaluate for urinary obstruction, particularly in older males with prostatic issues, as recommended by the European Heart Journal 6
Monitor creatinine and eGFR every 3-6 months based on CKD stage (G3a), as recommended by the American Diabetes Association 8
Regularly monitor potassium levels, especially when using ACE inhibitors, ARBs, or mineralocorticoid receptor antagonists, as recommended by the American Diabetes Association 8
Assess for albuminuria to determine risk of progression, as recommended by the American Diabetes Association 8

Target HbA1c <7.0% to slow progression of nephropathy, as recommended by the American Diabetes Association 9, 10, 11, 3, 12, 5, 13
Optimize blood pressure control with a target <130/80 mmHg for patients with albuminuria, and consider adding a non-dihydropyridine calcium channel blocker if blood pressure targets are not achieved with ACE inhibitor or ARB monotherapy, as recommended by the American Diabetes Association 3, 14
First-line therapy: ACE inhibitors or ARBs for patients with albuminuria, as recommended by the American Diabetes Association 8
Avoid discontinuing ACE inhibitors/ARBs prematurely, as a rise in creatinine up to 30% without hyperkalemia is acceptable and does not warrant discontinuation, as recommended by the American Diabetes Association 8
Ensure adequate hydration before contrast studies and calculate contrast volume to creatinine clearance ratio to predict maximum safe contrast volume, as recommended by the American College of Cardiology 7
Avoid dual RAS blockade due to increased risk of hyperkalemia and acute kidney injury, as recommended by the American Diabetes Association 10, 15, 16
ACE inhibitors can cause acute renal failure in specific situations, such as bilateral renal artery stenosis or stenosis in a solitary kidney, severe volume depletion, and concomitant use of NSAIDs or other nephrotoxic medications, as warned by the American College of Cardiology 17

Aim for 0.8 g/kg body weight per day of dietary protein for non-dialysis dependent stage G3 or higher CKD, as recommended by the American Diabetes Association 8
Limit sodium intake to help control blood pressure, as recommended by the American Heart Association
Achieve and maintain a healthy weight, as recommended by the American Heart Association
Consider protein restriction to 0.8 g/kg/day, though evidence for benefit is limited, as noted by the American Diabetes Association 10
Phosphate restriction is also recommended to prevent hyperphosphatemia, as recommended by multiple sources 3, 18, 19

Refer to nephrology if eGFR <30 mL/min/1.73m² or if severe albuminuria (≥300 mg/g creatinine) is present, as recommended by the American Diabetes Association 8
Refer patients with advanced diabetic kidney disease (ACR 2000 mg/g) to nephrology for specialist input, as recommended by the American College of Physicians 20, 10
Patients with eGFR <30 mL/min should be referred to nephrology for comprehensive management, as recommended by multiple sources 3, 18, 21, 19